Post-approval studies (Phase 4)Ended earlyNCT02401035What this trial is testingPREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric SubjectsWho this might be right forGastroesophageal Reflux Disease Pfizer 19
Early research (Phase 1)Study completedNCT00687245What this trial is testingPharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)Who this might be right forEndoscopically-Proven GERDReflux AstraZeneca 40
Large-scale testing (Phase 3)Study completedNCT00787891What this trial is testingThe Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric PatientsWho this might be right forGastroesophageal Reflux Disease (GERD) Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 127
Large-scale testing (Phase 3)Study completedNCT00141817What this trial is testingStudy Evaluating Pantoprazole in Children With GERDWho this might be right forGastroesophageal Reflux Wyeth is now a wholly owned subsidiary of Pfizer 41
Not applicableUnknownNCT01560598What this trial is testingAdipokines and the Risk of Reflux EsophagitisWho this might be right forVisceral ObesityReflux Esophagitis Seoul National University Hospital 600
Large-scale testing (Phase 3)Study completedNCT00300755What this trial is testingStudy Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)Who this might be right forGastroesophageal Reflux Wyeth is now a wholly owned subsidiary of Pfizer 60